18 results
424B5
IMPLQ
Impel Pharmaceuticals Inc
5 Oct 23
Prospectus supplement for primary offering
5:19pm
, including generic products; and
neither experimental nor investigational.
Adverse pricing limitations may hinder our ability to recoup our investment
10-K
j6hywl n9rn7o1f
29 Mar 22
Annual report
5:09pm
424B4
pyu0fzfrceu
10 Sep 21
Prospectus supplement with pricing info
4:01pm
DRS
enm6y3
25 Aug 21
Draft registration statement
12:00am
10-Q
c4n0z ff6r6g78e
7 Jun 21
Quarterly report
7:17am
424B1
eni0l0g4
23 Apr 21
Prospectus with pricing info
4:01pm
S-1
e7s3urdvg9df4 p03
2 Apr 21
IPO registration
3:04pm
DRS/A
mttyg7f eiq
23 Mar 21
Draft registration statement (amended)
12:00am
- Prev
- 1
- Next